查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1519817

2024-2032 年按疾病類型、治療類型、最終用戶和地區分類的心房顫動治療市場報告

Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球心房顫動治療市場規模達78億美元。

心房顫動 (AFib) 是指心率不規則且過快的心臟疾病，會增加中風、心臟衰竭和其他心臟相關併發症的風險。在這種情況下，上腔（心房）跳動不規則，與心臟下腔（心室）不協調，導致心悸、氣短和疲勞。它還可能導致血栓形成，從而擾亂流向其他器官的血液。 AFib 的主要類型包括陣發性、持續性、長期持續性和永久性 AFib，可以透過藥物和其他干預措施來調整心臟的電脈衝來治療。

心血管疾病（CVD）盛行率的上升是推動市場成長的關鍵因素之一。此類疾病在老年族群和患有其他疾病（例如糖尿病、高血壓和心血管疾病（CVD））的個體中非常普遍。這加上全球老年人口的穩定成長，正在推動市場的成長。此外，人們對微創 (MI) 外科手術的日益青睞也對小型手術設備、植入手術和遠端護理的需求產生了積極影響。此外，各種技術進步，例如用於去除受損心臟組織的導管消融裝置的開發以及創新的繪圖和記錄系統，是另一個生長誘導因素。其他因素，包括醫療保健基礎設施的改善以及醫學領域廣泛的研發（R＆D）活動，預計將進一步推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球心房顫動治療市場的表現如何，未來幾年又將如何表現？
  • COVID-19 對全球心房顫動治療市場有何影響？
  • 主要區域市場有哪些？
  • 基於無序類型的市場區隔是什麼？
  • 根據治療類型的市場分類是怎樣的？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球心房顫動治療市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球心房顫動治療市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場細分：依無序類型

  • 陣發性心房顫動
    • 市場走向
    • 市場預測
  • 持續性心房顫動
    • 市場走向
    • 市場預測
  • 永久性心房顫動
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依治療類型

  • 醫療程序
    • 市場走向
    • 外科手術
      • 迷宮手術
      • 導管消融
    • 非手術器械
      • 電復律
      • 診斷導管
      • 測繪和記錄系統
      • 心臟監測儀
      • 存取裝置
      • 左心耳及封堵裝置
      • 心內超音波心臟檢查 (ICE) 系統
    • 市場預測
  • 藥物
    • 市場走向
    • 藥品類別
      • 抗凝血劑
      • 抗心律不整藥
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 心臟實驗室
    • 市場走向
    • 市場預測
  • 門診手術中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Atricure Inc.
    • Biotronik
    • Boston Scientific Corporation
    • Cardiofocus Inc.
    • Hansen Medical Inc. (Auris Health)
    • Johnson & Johnson
    • Siemens Healthineers
    • Stereotaxis Inc.
Product Code: SR112024A2140

The global atrial fibrillation treatment market size reached US$ 7.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart's electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global atrial fibrillation treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disorder type, treatment type and end-user.

Breakup by Disorder Type:

Paroxysmal Atrial Fibrillation

Persistent Atrial Fibrillation

Permanent Atrial Fibrillation

Others

Breakup by Treatment Type:

Medical Procedures

Surgical Procedures

Maze Surgery

Catheter Ablation

Non-Surgical Procedures

Electric Cardioversion

Diagnostic Catheters

Mapping and Recording Systems

Cardiac Monitors

Access Devices

Left Atrial Appendage and Closure Devices

Intracardiac Echocardiography (ICE) Systems

Medication

Anticoagulants

Anti-Arrhythmics

Breakup by End-User:

Hospitals

Cardiac Labs

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers, Stereotaxis Inc., etc.

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global atrial fibrillation treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atrial Fibrillation Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disorder Type

  • 6.1 Paroxysmal Atrial Fibrillation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Persistent Atrial Fibrillation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Permanent Atrial Fibrillation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Medical Procedures
    • 7.1.1 Market Trends
    • 7.1.2 Surgical Procedures
      • 7.1.2.1 Maze Surgery
      • 7.1.2.2 Catheter Ablation
    • 7.1.3 Non-Surgical Devices
      • 7.1.3.1 Electric Cardioversion
      • 7.1.3.2 Diagnostic Catheters
      • 7.1.3.3 Mapping and Recording Systems
      • 7.1.3.4 Cardiac Monitors
      • 7.1.3.5 Access Devices
      • 7.1.3.6 Left Atrial Appendage and Closure Devices
      • 7.1.3.7 Intracardiac Echocardiography (ICE) Systems
    • 7.1.4 Market Forecast
  • 7.2 Medications
    • 7.2.1 Market Trends
    • 7.2.2 Drug Class
      • 7.2.2.1 Anticoagulants
      • 7.2.2.2 Anti-Arrhythmics
    • 7.2.3 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Atricure Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biotronik
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Boston Scientific Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Cardiofocus Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Hansen Medical Inc. (Auris Health)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Johnson & Johnson
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Siemens Healthineers
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Stereotaxis Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2023
  • Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2023
  • Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2023
  • Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2023
  • Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
  • Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
  • Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atrial Fibrillation Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Disorder Type (in Million US$), 2024-2032
  • Table 3: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Atrial Fibrillation Treatment Market Structure
  • Table 7: Global: Atrial Fibrillation Treatment Market: Key Players